DrugPatentWatch Database Preview
Details for Patent: 8,784,878
» See Plans and Pricing
Which drugs does patent 8,784,878 protect, and when does it expire?
Patent 8,784,878 protects AXIRON and is included in one NDA.
This patent has eighteen patent family members in eleven countries.
Summary for Patent: 8,784,878
| Title: | Transdermal delivery rate control using amorphous pharmaceutical compositions |
| Abstract: | A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents; one or more dermal penetration enhancers; and a volatile pharmaceutically acceptable carrier comprising a volatile solvent; and wherein the physiologically active agent and dermal penetration enhancer form an amorphous deposit upon evaporation of the volatile carrier, said amorphous deposit forming a reservoir within the stratum corneum; and (A) wherein the composition has a release rate profile of physiologically active agent so as to provide a ratio of the maximum concentration (C.sub.max) to the average concentration (C.sub.avg) for the physiologically active agent over the dosage interval within the range of 1 to 10. |
| Inventor(s): | Morgan; Timothy Matthias (Carlton North, AU), Wilkins; Nina Frances (Kensington, AU), Klose; Kathryn Traci-Jane (Bonreach, AU), Finnin; Barrie Charles (Toorak, AU), Reed; Barry Leonard (Essendon, AU) |
| Assignee: | Acrux DDS Pty Ltc. (West Melbourne, Victoria, AU) |
| Application Number: | 13/710,761 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; Use; |
Drugs Protected by US Patent 8,784,878
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | DISCN | Yes | No | Start Trial | Start Trial | Y | A METHOD OF TRANSDERMALLY DELIVERING TESTOSTERONE | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,784,878
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2003240301 | Start Trial | |||
| Brazil | 0312007 | Start Trial | |||
| Brazil | PI0312007 | Start Trial | |||
| Canada | 2489865 | Start Trial | |||
| Eurasian Patent Organization | 009024 | Start Trial | |||
| Eurasian Patent Organization | 200500084 | Start Trial | |||
| European Patent Office | 1534235 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
